282 related articles for article (PubMed ID: 28128742)
21. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
23. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
24. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
25. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
26. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
27. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.
Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ
J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329
[TBL] [Abstract][Full Text] [Related]
28. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.
Wasserkort R; Kalmar A; Valcz G; Spisak S; Krispin M; Toth K; Tulassay Z; Sledziewski AZ; Molnar B
BMC Cancer; 2013 Aug; 13():398. PubMed ID: 23988185
[TBL] [Abstract][Full Text] [Related]
29. The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
Song L; Guo S; Wang J; Peng X; Jia J; Gong Y; Yang B; Xiao W; Dong C; Liu H; Li Y
Biomark Med; 2018 Sep; 12(9):961-973. PubMed ID: 30043648
[TBL] [Abstract][Full Text] [Related]
30. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract][Full Text] [Related]
31. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer.
Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558
[TBL] [Abstract][Full Text] [Related]
32.
Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
[TBL] [Abstract][Full Text] [Related]
33. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.
Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y
Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784
[TBL] [Abstract][Full Text] [Related]
34. Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer.
Ma Z; Williams M; Cheng YY; Leung WK
Dis Markers; 2019; 2019():2673543. PubMed ID: 30944663
[TBL] [Abstract][Full Text] [Related]
35. A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene.
Leon Arellano M; García-Arranz M; Ruiz R; Olivera R; Magallares S; Olmedillas-Lopez S; Valdes-Sanchez T; Guadalajara H; García-Olmo D
Dis Markers; 2020; 2020():9761406. PubMed ID: 32566042
[TBL] [Abstract][Full Text] [Related]
36. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
[TBL] [Abstract][Full Text] [Related]
37. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
[TBL] [Abstract][Full Text] [Related]
38. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
39. Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study.
Liu Y; Tham CK; Ong SY; Ho KS; Lim JF; Chew MH; Lim CK; Zhao Y; Tang CL; Eu KW
Biomarkers; 2013 Aug; 18(5):399-405. PubMed ID: 23862763
[TBL] [Abstract][Full Text] [Related]
40. Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.
Song L; Li Y
Biomark Med; 2017 May; 11(6):415-418. PubMed ID: 28617104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]